¹Ì±¹ÀÇ ÇǺΠ´ë¿ëǰ ¹× ´ëüǰ ½ÃÀå ºÐ¼® : Medtech 360
Skin Replacements and Substitutes | Medtech 360 | Market Insights | United States
»óǰÄÚµå : 1461938
¸®¼­Ä¡»ç : Clarivate
¹ßÇàÀÏ : 2024³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 10,388 £Ü 14,447,000
Web Access and PDF Download (Corporate Use License) help
µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½º ÀÔ´Ï´Ù. À̸ÞÀÏ·Î ¸µÅ©¿Í ºñ¹Ð¹øÈ£¸¦ º¸³» µå¸³´Ï´Ù. ÀÎÅÍ³Ý ¿¬°á·Î ¿­¶÷ÀÌ °¡´ÉÇϰí PDF º¸°í¼­ ´Ù¿î·Îµå°¡ °¡´ÉÇÕ´Ï´Ù. ÀμⰡ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â PDF ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¹Ì±¹ÀÇ ÇǺΠ´ë¿ëǰ¡¤´ëüǰ ½ÃÀåÀº ¿Ï¸¸ÇÑ Áõ°¡°¡ Àü¸ÁµË´Ï´Ù. ÀÌ ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ´Â °ÍÀº ¾çÈ£ÇÑ Àα¸Åë°è, º´¿ø ÀÌ¿Ü È¯°æ¿¡¼­ ½Ã¼ú °Ç¼öÀÇ Áõ°¡, â»ó Ä¡À¯¸¦ À§ÇÑ ÇǺΠ´ë¿ëǰÀÇ Áö¼ÓÀû äÅÃÀÔ´Ï´Ù. ±×·¯³ª ÇâÈÄ »óȯ Á¦µµ ¹× ±ÔÁ¦ º¯°æ¿¡ °ü·ÃµÈ ºÒÈ®½Ç¼ºÀÌ ½ÃÀåÀÇ È®´ë¸¦ ¾à°£ ¾ïÁ¦ÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.

¹Ì±¹ÀÇ ÇǺΠ´ë¿ëǰ¡¤´ëüǰ ½ÃÀåÀ» ºÐ¼®ÇßÀ¸¸ç, ÀüüÀûÀÎ ½ÃÀå µ¿Çâ Àü¸Á(2019-2032³â) ¹× Á¦Ç° Ä«Å×°í¸®º° »ó¼¼ µ¿Çâ, ½ÃÀå °æÀï »óȲ(ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² µî), ÁÖ¿ä ½ÃÀå ÃËÁø¡¤¾ïÁ¦¿äÀÎ, ±â¼ú Çõ½Å ¹× COVID-19ÀÇ ¿µÇâ µîÀ» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

¹Ì±¹

°³¿ä

ÁÖ¿ä ¿ä¾à

ÁÖ¿ä ¸®Æ÷Æ® ¾÷µ¥ÀÌÆ®

ÇǺΠ´ë¿ëǰ¡¤´ëüǰ ½ÃÀå

»ý¹°ÇÐÀû ÇǺΠ´ë¿ëǰ¡¤´ëüǰ ½ÃÀå

»ýÇÕ¼º ÇǺΠ´ë¿ëǰ¡¤´ëüǰ ½ÃÀå

ºÎ·Ï

ºÐ¼® ¹æ¹ý

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The US skin replacements and substitutes market is expected to see gradual revenue growth. This growth will be driven by favorable demographics, increasing procedure volumes in nonhospital settings, and the continued adoption of skin replacements and substitutes for wound healing. However, uncertainties related to upcoming reimbursement systems and regulatory changes may somewhat constrain market expansion.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for skin replacements and substitutes in the US from 2019 through 2032.

Over the past three years there has been a notable increase in the use of nonhospital service locations.

Modifications in reimbursement policies within the US have impacted compensation for skin replacements and substitutes.

The adoption of biologic skin replacement and substitute products is on the rise.

Prominent competitive strategies in this domain include product launches, acquisitions, and partnerships.

Clinical data play a critical role for physicians when selecting skin replacements and substitutes.

Regulatory updates from the FDA regarding amniotic- and placenta-based products have impacted the competitive landscape.

Table of Contents

United States

Abstract

Executive Summary

Key Report Updates

Skin Replacement and Substitute Market

Biologic Skin Replacement and Substitute Market

Biosynthetic Skin Replacement and Substitute Market

Appendix

Methodology

Tables and Figures

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â